Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
iap0971 Non-Small Cell Lung Carcinoma	SUNHO（China）BioPharmaceutical CO., Ltd.	P1/2	CC (47)
ibi3014 Metastatic Neoplasm	Innovent Biologics (Suzhou) Co. Ltd.	P1/2	CC (47)
Ibrutinib Primary Mediastinal Large B-Cell Lymphoma	Yazeed Sawalha	P1/2	CC (47)
Icasp9M28Z T Cell Infusions Metastatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CC (47)
Idp-001 Non-Small Cell Lung Carcinoma	InduPro, Inc.	P1/2	CC (47)
Idp-023 Hematopoietic And Lymphoid System Neoplasm	Indapta Therapeutics, INC.	P1/2	CC (47)
Idp-023 Non-Hodgkin Lymphoma	Indapta Therapeutics, INC.	P1/2	CC (47)
Idp-121 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	IDP Discovery Pharma S.L.	P1/2	CC (47)
Idp-121 Diffuse Large B-Cell Lymphoma	IDP Discovery Pharma S.L.	P1/2	CC (47)
I-Dxd Small Cell Lung Carcinoma	Merck Sharp & Dohme LLC	P1/2	CC (47)
Ifebemtinib Small Cell Lung Carcinoma	InxMed (Shanghai) Co., Ltd.	P1/2	CC (47)
Ifinatamab Deruxtecan Castration-Resistant Prostate Carcinoma	Merck Sharp & Dohme LLC	P1/2	CC (47)
IM19 CAR-T cells Mantle Cell Lymphoma	Beijing Immunochina Medical Science & Technology Co., Ltd.	P1/2	CC (47)
IM19 CAR-T cells Lymphoproliferative Syndrome	Beijing Immunochina Medical Science & Technology Co., Ltd.	P1/2	CC (47)
IM19 CAR-T cells Non-Hodgkin Lymphoma	Beijing Immunochina Medical Science & Technology Co., Ltd.	P1/2	CC (47)
Imgn632 CD4+/CD56+ Hematodermic Neoplasm	AbbVie	P1/2	CC (47)
Imgn632 B-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P1/2	CC (47)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) B-Cell Neoplasm	BeOne Medicines	P1/2	CC (47)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide Breast Adenocarcinoma	Genmab	P1/2	CC (47)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide Ovarian Serous Adenocarcinoma	Genmab	P1/2	CC (47)
Immunoglobulin G1 [240-Alanine,241-Alanine], Anti-(Human Folate Receptor ?) (Human Monoclonal Pro1184 ?1-Chain, Complex With Human Monoclonal Pro1184 ?-Chain, Dimer, 214??,214???,226,226?,232,232?,235,235?-Octakis(Thioether) With N6-[39-[Bis(1-Deoxy-D-Glucitol-1-Yl)Amino]-1-Oxo-4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxanonatriacont-1-Yl]-N2-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]-L-Lysyl-L-Valyl-N5-(Aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]Carbonyl]Oxy]Methyl]Phenyl]-L-Ornithinamide Uterine Cancer	Genmab	P1/2	CC (47)
Immunoglobulin G1 [351-Alanine,386-Alanine,387-Alanine] Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Imm2902 ?1-Chain), Disulfide With 1-125-Signal Regulatory Protein ? [80-Alanine] (Human Isoform 4 Variant) Fusion Protein With Peptide Linker ((Ggggs)3) Fusion Protein With Human-Mus Musculus Monoclonal Imm2902 ?-Chain, Dimer Gastric Carcinoma	ImmuneOnco Biopharmaceuticals (Shanghai) Inc.	P1/2	CC (47)
Immunoglobulin G1, Anti-(Human/Macaca Fascicularis/Macaca Mulatta Killer Cell Lectin-Like Receptor Klrd1) (Human Monoclonal Dr-01 ?1-Chain), Disulfide With Human Monoclonal Dr-01 ?-Chain, Dimer Enteropathy-Associated T-Cell Lymphoma	Dren Bio	P1/2	CC (47)
Immunoglobulin G1, Anti-(Human/Macaca Fascicularis/Macaca Mulatta Killer Cell Lectin-Like Receptor Klrd1) (Human Monoclonal Dr-01 ?1-Chain), Disulfide With Human Monoclonal Dr-01 ?-Chain, Dimer Hepatosplenic T-Cell Lymphoma	Dren Bio	P1/2	CC (47)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Metastatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CC (47)

Showing 2401 to 2425 of 6,308 assets

PreviousPage 97 of 253Next